It comes as no surprise to read that quality targets do not reduce CHD (GP, 26 October).
As usual it has led to the knee jerk reaction that we need to drive cholesterol even lower to achieve improved results.
I take the opposite point of view and I suspect we need to review the role of statins in the prevention of CHD.
I have always tried to individualise treatment and started primary prevention for individual patients with a bad family history many years ago.
I suspect that this will not be the only quality indicator that proves completely useless in the fullness of time - a bit like flu vaccination.
Dr Thomas Cullen Clacton on Sea, Essex.